Phreesia Intrinsic Value – Phreesia Adds PAM Measure to Medicare Incentive System
December 2, 2023
☀️Trending News
Phreesia ($NYSE:PHR), a leading healthcare technology company, has recently announced that it has added the Patient Activation Measure (PAM) to the Medicare incentive system. The integration of PAM into the system will allow healthcare providers to increase patient engagement and ultimately improve patient outcomes. The PAM integration is the latest addition to their suite of solutions, which includes patient check-in, electronic payments, clinical data capture, among other offerings. The addition of PAM to the Medicare incentive system marks a major milestone for Phreesia, as it demonstrates the company’s commitment to improving patient engagement and outcomes.
PAM will enable providers to track and measure patient activation, allowing them to identify gaps in care and provide targeted interventions that are targeted to individual patient needs. With this integration, Phreesia is helping to ensure that Medicare patients receive the best care possible.
Share Price
On Friday, PHREESIA added a Patient Activation Measure (PAM) to its existing Medicare incentive system. The addition of PAM is designed to improve patient engagement and health outcomes by providing providers with a tool to assess and measure patient activation. As a result, PHREESIA’s stock opened at $15.3 and closed at $15.9, up by 3.1% from its prior closing price of 15.4. This new development is expected to benefit both the healthcare industry and PHREESIA’s shareholders. Phreesia_Adds_PAM_Measure_to_Medicare_Incentive_System”>Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Phreesia. More…
| Total Revenues | Net Income | Net Margin |
| 319.36 | -152.49 | -47.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Phreesia. More…
| Operations | Investing | Financing |
| -59.64 | -29.12 | -24.29 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Phreesia. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 340.44 | 93.42 | 4.48 |
Key Ratios Snapshot
Some of the financial key ratios for Phreesia are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 33.6% | – | -47.7% |
| FCF Margin | ROE | ROA |
| -26.6% | -37.3% | -28.0% |
Analysis – Phreesia Intrinsic Value
GoodWhale recently conducted an in-depth analysis of PHREESIA’s wellbeing. After our evaluation, we determined the fair value of PHREESIA’s shares to be approximately $53.3, calculated by our proprietary Valuation Line. Currently, PHREESIA stock is being traded at $15.9, greatly undervalued by 70.2%. We believe that this presents a great opportunity for investors to acquire PHREESIA shares at a discounted price. Phreesia_Adds_PAM_Measure_to_Medicare_Incentive_System”>More…
Peers
Its competitors include Sharecare Inc, Aclarion Inc, and Cloud DX Inc.
– Sharecare Inc ($NASDAQ:SHCR)
Sharecare is a digital health company that allows users to manage their health and wellness in one place. The company has a wide range of products and services, including a social media platform, a health information database, and a mobile app. The company also offers a variety of health and wellness products and services, including fitness tracking, nutrition counseling, and stress management.
– Aclarion Inc ($NASDAQ:ACON)
Aclarion Inc is a publicly traded company with a market cap of 6.36M as of 2022. The company has a Return on Equity of -186.66%. Aclarion is a provider of cloud-based software solutions for the management of enterprise content. The company’s products and services include content management, document management, records management, and compliance management. Aclarion’s solutions are used by organizations in a variety of industries, including healthcare, financial services, government, and education.
– Cloud DX Inc ($TSXV:CDX)
A market cap is the total value of all a company’s shares of stock. Market cap is calculated by multiplying a company’s shares outstanding by the current market price of one share. The return on equity is a financial ratio that measures the profitability of a company in relation to the equity. The company’s equity is the difference between its total assets and total liabilities. The company’s ROE is its net income divided by its equity.
The company’s market cap is 10.81M as of 2022. The company’s ROE is 111.76%. The company’s net income is its total assets minus its total liabilities. The company’s market cap is its shares outstanding multiplied by the current market price of one share.
Summary
Phreesia is an innovative healthcare technology company that offers a suite of solutions to make the patient experience better. Their solutions have been gaining recognition in recent years, and this has been evidenced by their stock price moving up the same day that the Centers for Medicare & Medicaid Services announced they would be adding a Patient Activation Measure to the Medicare incentive system. For investors, this is an exciting development, as Phreesia has already established itself as a leader in healthcare technology and its solutions have been proven to improve patient engagement and reduce administrative burden. With the CMS’s move to recognize their technology, Phreesia is well-positioned to grow rapidly and become a major force in the healthcare industry.
